Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
DOI:
https://doi.org/10.33448/rsd-v11i5.27592Keywords:
Intensive Care Center; Antimicrobial consumption; Microbial resistance.Abstract
The indiscriminate and excessive use of antimicrobials directly contributes to the development of bacterial resistance, increasing treatment expenses, morbidity and mortality rates, hospitalization time, and various adverse reactions. Therefore, the study's objective was to evaluate and quantify the consumption of antimicrobials used in the ICU of a Federal Public Hospital. Antimicrobial consumption was expressed as a defined daily dose (DDD) per 1000 patients/day. It was used in the World Health Organization (WHO) ATC/DDD classification. A total of 190 patients were admitted to the Intensive Care Unit, among which 51% were male, with a mean age of 53.4 ± 17.76 years, with the most prevalent age group being between 60 and 74 years (30.5 %). Among the diagnostic hypotheses of hospitalization, 26% were coronavirus infections. Of the hospitalized patients, 35.71% used some antimicrobial treatment, with meropenem being the most consumed (DDD 225.24). The study of the use of antimicrobials is an essential tool to guide the actions of the SCIH (Hospital Infection Control Service) that minimize microbial resistance and the indiscriminate and irrational use of these drugs and for the economic aspect. Furthermore, implementing an antimicrobial stewardship program optimizes the safe use of this important class of drugs.
References
Agência Nacional de Vigilância Sanitária (ANVISA) (2017). Gerência Geral de Tecnologia em Serviços de Saúde. Gerência de Vigilância e Monitoramento em Serviços de Saúde. Diretriz Nacional para Elaboração de Programa de Gerenciamento do Uso de Antimicrobianos em Serviços de Saúde.
Agência Nacional de Vigilância Sanitária (ANVISA) (2021). Programa de Uso Racional de Antimimcrobiano.
Balkhy, H. H. et al. (2018). Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study. Antimicrobial Resistance and Infection Control (2018) 7:156. https://doi.org/10.1186/s13756-018-0451-9.
Goossens, H., Ferech, M., Vander, Stichele. R. & Elseviers, M. (2005). Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 365(9459):579–87.
Barros, L. L. S., Maia, C. S. F. & Monteiro, M. C. (2016). "Risk factors associated to sepsis severity in patients in the Intensive Care Unit." Cadernos Saúde Coletiva. 24(4): 388-396.
Berild, D., Mohseni, A., Diep, L. M., Jensenius, M. & Ringertz, S.H.(2009). Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs. J Antimicrob Chemother. 57(2): 326-30.
Boucher, H. W., & Corey, G. R. (2008). Epidemiology of methicillin-resistant Staphylococcus aureus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 46 Suppl 5, S344–S349. https://doi.org/10.1086/533590.
Candeloro, C. L., Kelly, L. M., Bohdanowicz, E., Martin, C. M., & Bombassaro, A. M. (2012). Antimicrobial use in a critical care unit: a prospective observational study. The International journal of pharmacy practice, 20(3), 164–171. https://doi.org/10.1111/j.2042-7174.2011.00176.x.
Cars, O., Hedin, A., & Heddini, A. (2011). The global need for effective antibiotics-moving towards concerted action. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy, 14(2), 68–69. https://doi.org/10.1016/j.drup.2011.02.006.
Carneiro, M. et al (2011). "O uso de antimicrobianos em um hospital de ensino: uma breve avaliação." Revista da Associação Médica Brasileira. 57(4):421-424.
Chang, C. Y. & Schiano, T. D. (2007) Review article: drug hepatotoxicity. Aliment Pharmacol Ther. 25(10):1135–1351.
Cisneros, J. M., Ortiz-Leyba, C., Lepe, J. A., Obando, I., Conde, M., Cayuela, A., & Gil, M. V. (2010). Uso prudente de antibióticos y propuestas de mejora desde la medicina hospitalaria [Prudent use of antibiotics and suggestions for improvement from hospital-based medicine]. Enfermedades infecciosas y microbiologia clinica, 28 Suppl 4, 28–31. https://doi.org/10.1016/S0213-005X(10)70039-2.
De Sousa Feitosa, T., Mendes, A. L. R., Ferreira, P. R. B. & Coêlho, M. L. (2021). "Aplicações de indicadores como estratégia de gerenciamento do uso e custo dos antimicrobianos em um hospital universitário." Research, Society and Development. 10(6), e43610615899-e43610615899.
Dumartin, C., L'Hériteau, F., Péfau, M., Bertrand, X., Jarno, P., Boussat, S., Angora, P., Lacavé, L., Saby, K., Savey, A., Nguyen, F., Carbonne, A., & Rogues, A. M. (2010). Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. The Journal of antimicrobial chemotherapy, 65(9), 2028–2036. https://doi.org/10.1093/jac/dkq228.
Grillo, V. T. R. S., Gonçalves, T. G., Júnior, J. C., Paniágua, N.C. & Teles, C. B. G. (2013). Incidência bacteriana e perfil de resistência a antimicrobianos em pacientes pediátricos de um hospital público de Rondônia, Brasil. Rev Ciênc Farm Bás Apl. 34(1):117-23.
Herzke, C. A.; Chen, L. F., Anderson, D. J., Choi, Y., Sexton, D. J., Kaye, K. S. (2009). Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss. Infect Control Hosp Epidemiol. 30(11):1057-61.
Leekha, S., Terrell, C. L. & Edson, R. S.(2011). General principles of antimicrobial therapy. Mayo Clin Proc.86(2):156-167.
Lode, H (2010). Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections. Am J Med. 123(4 Suppl): S26-38.
Loureiro, R. J., Roque, F., Rodrigues, A.T., Herdeiro, M.T. & Ramalheira, E. (2016). O uso de antibióticos e as resistências bacterianas: breves notas sobre a sua evolução. Rev Port Saúde Púb. 34(1):77-84.
Marquet, K., Liesenborgs, A., Bergs, J., Vleugels, A. & Claes, N. (2015). Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 19(1):63. https://doi.org/10.1186/s13054-015-0795-y.
Meyer, E., Schwab, F., Gastmeier, P., Rueden, H., & Daschner, F. D. (2006). Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection, 34(6), 303–309. https://doi.org/10.1007/s15010-006-6619-x.
Oliveira, A. C. & Paula, A. O.(2021). Discontinuation of antimicrobials and costs of treating patients with infection. Acta Paulista de Enfermagem [online]. v. 25, n. spe2 [Acessado 29 Janeiro 2022], pp. 68-74. Disponível em: <https://doi.org/10.1590/S0103-21002012000900011>. ISSN 1982-0194. https://doi.org/10.1590/S0103-21002012000900011.
Onzi, O. S., Hoffman, S. P. & Carmargo, A. L. (2011) Avaliação do consumo de antimicrobianos injetáveis de um hospital privado no ano de 2009. Rev. Bras. Farm. Hosp. Serv. Saúde. 2(2):20-25.
Rocha, M. A.; Carneiro, P. M. & Castilho SR. Estudo da utilização de medicamentos antimicrobianos de 2003 a 2004 em pacientes adultos em hospital terciário no Rio de Janeiro. Rev. Bras. Farm. 90 (1):50-53.
Rosenthal, V. D., Maki, D. G., Mehta, A., Alvarez-Moreno, C., Leblebicioglu, H., Higuera, F., Cuellar, L. E., Madani, N., Mitrev, Z., Dueñas, L., Navoa-Ng, J. A., Garcell, H. G., Raka, L., Hidalgo, R. F., Medeiros, E. A., Kanj, S. S., Abubakar, S., Nercelles, P., Pratesi, R. D., & International Nosocomial Infection Control Consortium Members (2008). International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. American journal of infection control, 36(9), 627–637. https://doi.org/10.1016/j.ajic.2008.03.003.
Sociedade Brasileira de Microbiologia (SBM) (2017). A ameaça das super Bactérias. Rev Microb In Foco. 8(31):11-16.
Souza, F. C., Baroni, M. M. F. & Roese, F.M. (2017). Perfil de utilização de antimicrobianos na unidade de terapia intensiva de um hospital público. Rev. Bras. Farm. Hosp. Serv. Saúde. 8(4):37-44.
Souza, G. N., Porto, M. de J. ., Santos, J. P. dos ., Freitas, A. L. ., & Carvalho, P. P. . (2021). Profile of restricted use antimicrobial requirements in na Intensive Care Unit . Research, Society and Development, 10(8), e15710816565. https://doi.org/10.33448/rsd-v10i8.16565.
Sousa, P. C. P., Rocha, M. V. A. P., Sousa, F. S. P. & Nogueira, N. A. P. (2009). Utilização de antibacterianos em Unidade de Terapia Intensiva. Rev. Cient. Inter. 4(18):1-15.
Souza, R. R. de., Nascimento, . M. A., Ederli, R. B., Santos, E. C. M., Santos, I. A. dos, & Ederli. J. P. B. (2020). Multi-resistant Acinetobacter baumannii emergence associated with healthcare infections: Meta-analysis. Research, Society and Development, 9(10), e1889108270. https://doi.org/10.33448/rsd-v9i10.8270.
Walther, S. M., Erlandsson, M., Burman, L. G., Cars, O., Gill, H., Hoffman, M., Isaksson, B., Kahlmeter, G., Lindgren, S., Nilsson, L., Olsson-Liljequist, B., Hanberger, H., & Icustrama Study Group (2002). Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta anaesthesiologica Scandinavica, 46(9), 1075–1081. https://doi.org/10.1034/j.1399-6576.2002.460904.x.
Youssif, E., Aseeri, M., & Khoshhal, S. (2018). Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia. Journal of infection and public health, 11(4), 486–490. https://doi.org/10.1016/j.jiph.2017.09.001.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Maria Gorete Lima Marinho; Suzany Helena da Silva Cândido; Mírian Brasil Magalhães de Oliveira; Rebeka Caribé Badin
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
